FDA
approval
· 2022-12-01
FDA Approved: BIMATOPROST — Supplemental Application (Apotex Corp.)
Summary
FDA approved a supplemental application for Bimatoprost from Apotex Corp. under an Abbreviated New Drug Application (ANDA). The approval confirms the generic pr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BIMATOPROST (BIMATOPROST)